-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
PRM1201 is a traditional Chinese medicine formula composed of 7 Chinese herbal medicines
Colorectal cancer
In this study, patients with stage III colon cancer who underwent radical surgical resection were randomly divided into adjuvant chemotherapy (FOLFOX q2w for 6 months, or CapeOx q3w for 6 months) + PRM1201 (chemotherapy + PRM1201 group) or adjuvant chemotherapy + placebo (Chemotherapy + placebo group)
Colon cancer
From January 2016 to June 2016, 420 patients from 7 medical centers were screened and 370 patients were included in the study
Screening
The 1-year, 2-year, and 3-year DFS rates in the chemotherapy+PRM1201 group were 91.
The 1-year, 2-year, and 3-year DFS rates in the chemotherapy+PRM1201 group were 91.
DFS
Adverse events
In summary, studies have shown that the addition of Chinese medicine formula PRM1201 can improve the effect of adjuvant treatment of colon cancer, and can become an effective choice in clinical practice
Studies have shown that the addition of Chinese medicine formula PRM1201 can improve the adjuvant treatment effect of colon cancer, and can become an effective choice in clinical practice
Jia R, Liu N, Cai G, et al (2021) Effect of PRM1201 Combined With Adjuvant Chemotherapy on Preventing Recurrence and Metastasis of Stage III Colon Cancer: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Jia R, Liu N, Cai G, et al (2021) Effect of PRM1201 Combined With Adjuvant Chemotherapy on Preventing Recurrence and Metastasis of Stage III Colon Cancer: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Front.
Oncol.
11 :618793.
doi: 10.
3389/fonc.
2021.
618793
leave a message here